Armistice Capital Master Fund Ltd., 10% Owner at AMAG PHARMACEUTICALS, INC. (AMAG), bought 24,000 shares at $4.87 ($117K) on 2020-03-16, disclosed to the SEC on 2020-03-18.
Open-market purchase of $117k AMAG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| AVTX | BUY | 2022-01-11 | $1.1M | — | Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |